20077 ā
Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles; Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
ALTERING INFLAMMATORY STATES OF IMMUNE CELLS IN VIVO BY MODULATING CELLULAR ACTIVATION STATES
#2SOLID DISPERSION OF CURCUMIN DERIVATIVE METHOD FOR PREPARING SAME, AND USE THEREOF
#3SOLID CYCLODEXTRIN COMPLEXES FOR OPHTHALMIC ACTIVE PHARMACEUTICAL INGREDIENT DELIVERY
#4ANESTHETIC AGENT MICRO AND NANO PARTICLES, AND METHODS OF MAKING AND USING THE SAME
#5COMPOSITIONS AND METHODS FOR DELIVERY OF IMMUNE CELLS TO TREAT UN-RESECTABLE OR NON-RESECTED TUMOR CELLS AND TUMOR RELAPSE
#6COMPOSITIONS FOR AQUACULTURING
#7THERAPEUTIC CONSTRUCTS FOR CO-DELIVERY OF ANTI-CANCER AGENT(S) AND IMMUNE CHECKPOINT INHIBITOR(S)
#8SYNERGISTIC ENHANCEMENT OF THE DELIVERY OF NUCLEIC ACIDS VIA BLENDED FORMULATIONS
#9Nilotinib Compositions with Enhanced Solubility
#10COMPOSITIONS, DEVICES, AND METHODS FOR INTRANASAL DELIVERY OF DRY POWDER EPINEPHRINE
#11SOLID DISPERSIONS HAVING STABILIZED EMULSION PARTICLES
#12SOLID COMPOSITION AND METHOD FOR PRODUCING THE SAME
#13ANTIVIRAL PRODRUGS AND NANOFORMULATIONS THEREOF
#14Nutritive Polypeptides and Formulations Thereof, and Methods of Production and Use Thereof
#15PRODUCTION OF ENCAPSULATED NANOPARTICLES AT COMMERCIAL SCALE
#16PHARMACEUTICAL COMPOSITIONS
#17PHARMACEUTICAL FORMULATION WITH IMPROVED SOLUBILITY AND BIOAVAILABILITY
#18GLYCOPYRROLATE SALTS
#19SYSTEMS, COMPOSITIONS, AND METHODS RELATED TO INJECTABLE HYDROGELS
#20NONSTEROIDAL ANTI-INFLAMMATORY DRUG COMPLEXES AND METHODS OF MAKING AND USING
#21TREATMENT OF HEPATITIS DELTA VIRUS INFECTION
#22COMPOSITIONS AND FORMULATION METHODS FOR SUSTAINED LOCAL RELEASE OF ANTIFIBROTICS
#23PHARMACEUTICAL COMPOSITIONS COMPRISING NILOTINIB
#24TOPICAL POWDER VEHICLE FOR THE TREATMENT OF ALOPECIA
#25FORMULATIONS OF VILOXAZINE
#26PHARMACEUTICAL COMPOSITION CONTAINING 1-{2-[(3S,4R)-1-{[(3R,4R)-1-CYCLOPENTYL-3-FLUORO-4-(4-METHOXYPHENYL)PYRROLIDIN-3-YL]CARBONYL}-4-(METHOXYMETHYL)PYRROLIDIN-3-YL]-5-(TRIFLUOROMETHYL)PHENYL}PIPERIDINE-4-CARBOXYLIC ACID OR PHARMACEUTICALLY ACCEPTABLE SALT OR CO-CRYSTAL THEREOF
#27NANOCRYSTALLINE PREPARATION OF ROCK2 INHIBITOR AND PREPARATION METHOD THEREFOR
#28AMORPHOUS DOSAGE FORM CONTAINING EBSELEN
#29PACKAGING FOR RAPIDLY INFUSING COMPOSITION
#30COMPOSITIONS AND METHODS FOR THE PREVENTION OF LOSS OF ORGAN FUNCTION ASSOCIATED WITH CHRONIC ORGAN DISEASE
#31AMORPHOUS CABOZANTINIB PARTICLES AND USES THEREOF
#32Compositions and Dosage Forms for Treatment of HPV Infection and HPV-Induced Neoplasia
#33PROTEIN AND BIOPOLYMER COMPLEXES AND METHODS OF MAKING AND USING THE SAME
#34SOLUBLE NEEDLE ARRAYS FOR DELIVERY OF INFLUENZA VACCINES
#35COMPOSITIONS AND METHODS FOR TREATING PULMONARY VASCULAR DISEASE
#36AMORPHOUS SOLID DISPERSIONS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
#37COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES
#38a-ACID AND/OR B-ACID BASED COPOSITIONS FROM HUMULUS FOR USE IN A HUMAN AND/OR VETERINARY APPLICATION
#39ANTIBIOTIC FORMULATIONS FOR LOWER BACK PAIN
#40NOVEL USE OF POLYMER COMBINATION
#41PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOF
#42EXTENDED NITRIC OXIDE-RELEASING POLYMERS VIA FUNCTIONALIZED MESOPOROUS SILICA NANOPARTICLES
#43VACCINE COMPOSITION COMPRISING AN ANTIGEN AND A TLR3 AGONIST
#44FORMULATIONS OF VILOXAZINE
#45SOLID COMPOSITION COMPRISING SOLUBILISED BRADYKININ B2-RECEPTOR ANTAGONISTS
#46FORMULATIONS OF VILOXAZINE
#47METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR THE TREATMENT OF VIRAL DISEASES
#48HEMOSTATIC MATERIAL AND SPRAY
#49Oral Rapamycin Nanoparticle Preparations and Use
#50METHOD FOR PRESERVING SOLID COMPOSITION THAT CONTAINS FORM II TYPE CRYSTALS OF REDUCED COENZYME Q10, AND PACKING THAT CONTAINS SAID SOLID COMPOSITION
#51GLYCOPYRROLATE SALTS
#52FORMATION OF PARTICLES INCLUDING AGENTS
#53ANTIEMETIC COMBINATIONS
#54PREPARATION OF SOLID CYCLODEXTRIN COMPLEXES FOR OPHTHALMIC ACTIVE PHARMACEUTICAL INGREDIENT DELIVERY
#55DRY POWDER COMPOSITIONS OF TREPROSTINIL PRODRUGS AND METHODS OF USE THEREOF
#56AMORPHOUS (A-POLYMORPHIC) PSILOCYBIN
#57THERAPEUTIC COMPOUNDS, FORMULATIONS, AND USE THEREOF
#58SOLID DISPERSIONS CONTAINING AN APOPTOSIS-INDUCING AGENT
#59PHARMACEUTICAL FORMULATION
#60PROCESSES FOR PRODUCING COMPOSITIONS WITH IMPROVED SAFETY PROFILE HAVING LIPASE ACTIVITY AND COMPOSITIONS SUITABLE FOR PHARMACEUTICAL USE
#61PHARMACEUTICAL COMPOSITIONS COMPRISING NILOTINIB
#62NOVEL COMPOSITIONS
#63BENDAMUSTINE SOLID DISPERSIONS AND CONTINUOUS INFUSION
#64BEADED NONWOVEN MEMBRANE AS A DRUG DELIVERY SYSTEM
#65COMPOSITIONS OF TRIGLYCERIDES AND USES THEREOF
#66COMPOSITIONS OF TRIGLYCERIDES AND USES THEREOF
#67COMPOSITIONS OF TRIGLYCERIDES AND USES THEREOF
#68DOSAGE FORM COMPOSITIONS COMPRISING AN INHIBITOR OF BRUTON'S TYROSINE KINASE
#69COMPOSITIONS FOR AQUACULTURING
#70MATTER OF COMPOSITION, SYNTHESIS, FORMULATION AND APPLICATION OF FL 118 PLATFORM POSITIONS 7 AND 9-DERIVED ANALOGUES FOR TREATMENT OF HUMAN DISEASE
#71A POLYMER TO INCREASE THE BIOAVAILABILITY OF A PHARMACEUTICAL COMPOUND
#72Sustained Release Olanzapine Formulations
#73SOLID FORMS OF 1-{3-[3-(4-CHLOROPHENYL) PROPOXY] PROPYL} PIPERIDINE HYDROCHLORIDE AND PROCESS FOR THE PREPARATION THEREOF
#74Method for improving the dissolution profile of a biologically active material
#75SALTS, COCRYSTALS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF TREATMENT INVOLVING THE SAME
#76AMORPHOUS SOLID DISPERSION GANAXOLONE FORMULATION
#77TERNARY CO-AMORPHOUS FORMS OF DRUGS, PROTEINS, AND WATER-SOLUBLE POLYMERS
#78Methods of Making and Using Polyphenols Complexed With a Protein, Peptide, Amino Acid, Polysaccharide, Disaccharide, or Monosaccharide
#79SOLID DISPERSION, PREPARATION METHOD, AND PHARMACEUTICAL COMPOSITION THEREOF
#80PHARMACEUTICAL COMPOSITION
#81IMPROVED DRUG PROCESSING METHODS TO INCREASE DRUG LOADING
#82SOLUBLE NEEDLE ARRAYS FOR DELIVERY OF INFLUENZA VACCINES
#83Pharmaceutical composition
#84POLYMER PARTICLES
#85OPHTHALMIC FORMULATIONS OF TYROSINE KINASE INHIBITORS, METHODS OF USE THEREOF, AND PREPARATION METHODS THEREOF
#86PHARMACEUTICAL FORMULATION
#87IMPLANTABLE THERAPEUTIC DELIVERY SYSTEM AND METHODS THEREOF
#88DRY POWDER FOAMABLE FORMULATIONS FOR DELIVERY OF MEDICAMENTS THROUGH THE MUCOSA
#89Production of encapsulated nanoparticles at high volume fractions
#90COLON-TARGETED ACTIVE AGENT DELIVERY CARRIER AND USES THEREOF
#91COMPOSITIONS AND METHODS FOR DEEP DERMAL DRUG DELIVERY
#92THERAPEUTIC CONSTRUCTS FOR CO-DELIVERY OF ANTI-CANCER AGENT(S) AND IMMUNE CHECKPOINT INHIBITOR(S)
#93GASTRIC RESIDENCE SYSTEMS WITH RELEASE RATE-MODULATING FILMS
#94NOVEL USE OF POLYMER COMBINATION
#95NANOSPHERES OF SEC14-LIKE PROTEINS AND COGNATE LIGANDS
#96AMORPHOUS (A-POLYMORPHIC) PSILOCYBIN
#97PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANT
#98PROCESSES FOR MAKING CYCLIC LIPID IMPLANTS FOR INTRAOCULAR USE
#99GEOMETRIC CONFIGURATIONS FOR GASTRIC RESIDENCE SYSTEMS
#100SUSTAINED RELEASE PARTICLE FORMULATIONS
#101HIGH DENSITY PEPTIDE POLYMERS
#102PROTEIN CONTAINING BIO-ACTIVE COMPOSITIONS COMPRISING CELLULOSE MICROPARTICLE CARRIERS
#103NANOPARTICLES FOR DELIVERY OF THERAPEUTICS TO THE EYE FOR TREATMENT OF GLAUCOMA
#104NANOSTRUCTURE OR MICROSTRUCTURE AND METHOD FOR PRODUCING SAME
#105Treatment of hepatitis delta virus infection
#106CO-AMORPHOUS FORMS FOR USE IN CANCER THERAPY
#107METHOD OF DELIVERING PROTEINS INTO CELLS
#108METHODS OF TREATING OR PREVENTING ALLERGIES AND CHRONIC NASAL CONGESTION
#109IMMUNOGENIC COMPOSITIONS AND USES THEREOF
#110GASTRIC RESIDENCE SYSTEMS COMPRISING BUPRENORPHINE AND NALOXONE
#111COMPOSITIONS AND METHODS FOR THE TREATMENT AND PROPHYLAXIS OF SURGICAL SITE INFECTIONS
#112FORMULATION OF A MULTI LAYERED PELLET COMPRISING MELATONIN
#113Heteromultivalent Spherical Nucleic Acids and Uses in Therapeutic and Diagnostic Applications
#114POLYMERIC IMPLANTS
#115COMPOSITION COMPRISING AT LEAST ONE NATURAL OR SYNTHETIC N-ALKYLAMIDE AS ACTIVE SUBSTANCE AND ITS MANUFACTURING PROCESS
#116PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION OF A BCL 2 FAMILY INHIBITOR
#117DISSOCIATING POLYMER MATRIX COMPOSITIONS OF FULVESTRANT AND METHODS OF THEIR MAKING AND USE
#118PROCESS FOR PREPARATION OF CABOZANTINIB
#119PROCESS FOR CONTINUOUS HOT MELT GRANULATION OF LOW SOLUBLE PHARMACEUTICALS
#120POWDERY PREPARATION AND METHOD FOR MANUFACTURING SAME
#121AMORPHOUS FORM AND COMPOSITION CONTAINING SAID AMORPHOUS FORM
#122STABLE DOCETAXEL ALBUMIN NANOPARTICLE COMPOSITION
#123POWDER COMPOSITION FOR DISINFECTION OF THE TEATS OF DAIRY ANIMALS
#124Pharmaceutical composition and administrations thereof
#125Simplified Method for Making Shelf Stable Highly Water Soluble Anhydrous Compositions Of Cyclodextrin Complexes of Macrocyclic Lactones
#126COMPOSITIONS AND DOSAGE FORMS FOR TREATMENT OF HPV INFECTION AND HPV-INDUCED NEOPLASIA
#127Compositions comprising an urolithin compound
#128PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANT
#129PHARMACEUTICAL FORMULATION COMPRISING CINEOLE AND AMOXICILLIN
#130FORMULATION OF A MULTI LAYERED PELLET COMPRISING MELATONIN
#131COMPOSITIONS AND METHODS FOR DELIVERY OF IMMUNE CELLS TO TREAT UN-RESECTABLE OR NON-RESECTED TUMOR CELLS AND TUMOR RELAPSE
#132INTRANASAL DHE FOR THE TREATMENT OF HEADACHE
#133Antiviral prodrugs and nanoformulations thereof
#134Preparation of solid cyclodextrin complexes for ophthalmic active pharmaceutical ingredient delivery
#135FORMULATIONS OF DEFERASIROX AND METHODS OF MAKING THE SAME
#136INTRAVAGINAL FORMULATION
#137DRUG DELIVERY COMPOSITION, METHOD FOR PRODUCING SAME AND USE THEREOF
#138Solid Pharmaceutical Compositions for Treating HCV
#139FATTY ACID-MODIFIED POLYMER NANOPARTICLES, AND USE THEREOF
#140Dry powder compositions of treprostinil prodrugs and methods of use thereof
#141PHARMACEUTICAL COMPOSITION
#142Pharmaceutical composition
#143MICROPARTICLES AND NANOPARTICLES HAVING NEGATIVE SURFACE CHARGES
#144ORAL DOSAGE FORMS HAVING A HIGH LOADING OF A METHYL HYDROGEN FUMARATE PRODRUG
#145Oral pouch product
#146SOLID DISPERSION, PHARMACEUTICAL PREPARATIONS, PREPARATION METHOD, AND APPLICATION THEREOF
#147PACKAGING FOR RAPIDLY INFUSING COMPOSITION
#148IMMUNE-MODIFYING NANOPARTICLES FOR THE TREATMENT OF INFLAMMATORY DISEASES
#149MICROPARTICLES CONTAINING BUPROPION
#150FORMULATIONS
#151Compositions and methods for nanoparticle lyophile forms
#152COLON-TARGETED ACTIVE AGENT DELIVERY CARRIER AND USES THEREOF
#153PHARMACEUTICAL COMPOSITION COMPRISING A CAP-DEPENDENT ENDONUCLEASE INHIBITOR
#154RAPIDLY INFUSING COMPOSITIONS WITH METHOTREXATE AND TREATMENT METHODS
#155RAPIDLY INFUSING CANNABINOID COMPOSITIONS, PROCESSES OF MANUFACTURE, AND METHODS OF USE
#156COMPOSITIONS AND METHODS FOR DEEP DERMAL DRUG DELIVERY
#157SOLUBLE NEEDLE ARRAYS FOR DELIVERY OF INFLUENZA VACCINES
#158AMORPHOUS SOLID DISPERSION GANAXOLONE FORMULATION
#159Compositions and devices to administer pharmaceutical compositions nasally
#160FORMULATIONS OF VILOXAZINE
#161AMORPHOUS CABOZANTINIB PARTICLES AND USES THEREOF
#162BENDAMUSTINE SOLID DISPERSIONS AND CONTINUOUS INFUSION
#163PRODUCTION OF ENCAPSULATED NANOPARTICLES AT COMMERCIAL SCALE
#164Proinsulin Peptides for Type I Diabetes
#165CHEMOEMBOLIZATION AGENTS
#166DOSAGE FORM COMPOSITIONS COMPRISING AN INHIBITOR OF BRUTON'S TYROSINE KINASE
#167Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune checkpoint inhibitor
#168Biodegradable polymer formulations for extended efficacy of botulinum toxin
#169RESVERATROL COMPOSITION, PREPARATION METHOD AND APPLICATION THEREOF
#170HIGH-STRENGTH ORAL TAXANE COMPOSITIONS AND METHODS
#171NASAL POWDER FORMULATION FOR TREATMENT OF HYPOGLYCEMIA
#172CURCUMINOID COMPOSITES
#173RAPIDLY INFUSING PLATFORM AND COMPOSITIONS FOR THERAPEUTIC TREATMENT IN HUMANS
#174COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES
#175SUSTAINED RELEASE PARTICLE FORMULATIONS
#176TABLET FORMULATION FOR CGRP ACTIVE COMPOUNDS
#177LONG-ACTING FORMULATIONS
#178METHOD FOR PRODUCING ORGANIC MATERIAL MICROPARTICLES, AND METHOD FOR MODIFYING ORGANIC MATERIAL MICROPARTICLES
#179NUCLEIC ACID-CONTAINING LIPID PARTICLES AND RELATED METHODS
#180Compositions and methods for deep dermal drug delivery
#181PHARMACEUTICAL FORMULATION OF PALBOCICLIB AND A PREPARATION METHOD THEREOF
#182Pharmaceutical compositions comprising lonafarnib and ritonavir
#183NEW PRODUCT
#184INJECTABLE NEUROSTEROID FORMULATIONS CONTAINING NANOPARTICLES
#185SOLID COMPOSITIONS OF TRIGLYCERIDES AND USES THEREOF
#186Thermo-kinetic mixing for pharmaceutical applications
#187COMPOSITION COMPRISING AT LEAST ONE PROTOBERBERINE ALKALOID AND METHOD FOR MANUFACTURING SAME
#188HYDROGEL-MATRIX ENCAPSULATED OLIGONUCLEOTIDES AND METHODS FOR FORMULATING AND USING ENCAPSULATED OLIGONUCLEOTIDES
#189MACROCYCLIC LACTONE FORMULATIONS, METHODS OF THEIR PREPARATION AND USE OF THE FORMULATIONS IN TREATING PATHOLOGIES SECONDARY TO OPHTHALMIC PARASITES
#190Solid dosage form of a nicotine concentration
#191Antibiotic formulations for lower back pain
#192METHODS OF USING SOLID DISPERSIONS OF RIFAXIMIN FOR THE TREATMENT OF SICKLE CELL DISEASE
#193OPHTHALMIC SUSPENSION COMPOSITION
#194Method for the Production of Commercial Nanoparticle and Microparticle Powders
#195NOVEL FORMULATION OF MELOXICAM
#196PHARMACEUTICAL FORMULATION
#197DRUG DELIVERY CARRIER INCLUDING PLGA AND BETA-CYCLODEXTRIN CONTAINING DRUG
#198CONTROLLED RELEASE SYSTEM FOR PULMONARY DELIVERY OF SURFACTANT PROTEIN D
#199AN ORAL PHARMACEUTICAL COMPOSITION COMPRISING AN EXTRACT OF COMBINED HERBS COMPRISING LONGANAE ARILLUS FOR THE TREATMENT OR ALLEVIATION OF INFLAMMATORY DISEASE AND THE USE THEREOF
#200Dry powder foamable formulations for delivery of medicaments through the mucosa
#201RELEASE OF ACTIVE INGREDIENTS USING SILICON-CONTAINING POLYMERS
#202GABA COMPLEX COMPOSITION
#203Ophthalmic drug sustained release formulation and uses thereof
#204NANOPARTICLES FOR USE IN THE TREATMENT AND DIAGNOSIS OF CNS DISORDERS
#205PHARMACEUTICAL COMPOSITION CONTAINING REGORAFENIB AND A STABILIZING AGENT
#206Gelling multiparticulates
#207SOLID DISPERSIONS
#208COMPOSITIONS COMPRISING MOLECULARLY SEPARATED CANNABINOIDS AND TERPENE BLENDS AND METHODS OF PRODUCING
#209FORMULATION, COMPOSITION OR FOODSTUFF ADDITIVES FOR THE MODIFICATION OF GLYCEMIC RESPONSE METHODS OF MANUFACTURING AND USING THE SAME
#210Treatment of hepatitis delta virus infection
#211PREPARATION OF SOLID CYCLODEXTRIN COMPLEXES FOR OPHTHALMIC ACTIVE PHARMACEUTICAL INGREDIENT DELIVERY
#212Pharmaceutical Formulation with Improved Solubility and Bioavailability
#213PREPARATION OF SOLID CYCLODEXTRIN COMPLEXES FOR OPHTHALMIC ACTIVE PHARMACEUTICAL INGREDIENT DELIVERY
#214PHARMACEUTICAL COMPOSITION COMPRISING A POTENT INHIBITOR OF URAT1
#215SNUFF COMPOSITION
#216CO-AMORPHOUS FORMS OF BETA-LACTOGLOBULIN AND A DRUG SUBSTANCE
#217INTRANASAL DHE FOR THE TREATMENT OF HEADACHE
#218Dry powder compositions of treprostinil prodrugs and methods of use thereof
#219Compositions and methods for the treatment and prophylaxis of surgical site infections
#220ANESTHETIC AGENT MICRO AND NANO PARTICLES, AND METHODS OF MAKING AND USING THE SAME
#221Microparticles and nanoparticles having negative surface charges
#222ALBUMIN-PD-1 PACLITAXEL NANOPARTICLE COMPLEX COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
#223Wound treatment containing collagen and a gelatin-reducing agent, and method for promoting wound healing
#224PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANT
#225LOCALIZED IMMUNOSUPPRESSION OF ALLOGRAFTS FOR PERIPHERAL NERVE REPAIR
#226DELIVERY OF DRUG NANOPARTICLES AND METHODS OF USE THEREOF
#227LOCALIZED IMMUNOSUPPRESSION OF ALLOGRAFTS FOR PERIPHERAL NERVE REPAIR
#228CANNABIS TABLET FORMULATIONS AND COMPOSITIONS AND METHODS OF MAKING THE SAME
#229Formulations of 4-Methyl-5-(Pyrazin-2-yl)-3H-1,2-Dithiole-3-Thione, Taste-Modified Formulations, and Methods of Making and Using Same
#230Small Molecule Agents, Compositions, and Formulations, for Internal Use, Displaying Inhibitory Activity Against Gram-positive and/or Gram-negative Organisms
#231NUCLEIC ACID-CONTAINING LIPID PARTICLES AND RELATED METHODS
#232CATIONIC NANODRUG, PREPARATION METHOD THEREFOR, AND DRUG-LOADED IMPLANTABLE MEDICAL DEVICE
#233TELODENDRIMERS WITH RIBOFLAVIN MOIETIES AND NANOCARRIERS AND METHODS OF MAKING AND USING SAME
#234OPHTHALMIC FORMULATIONS OF TYROSINE KINASE INHIBITORS, METHODS OF USE THEREOF, AND PREPARATION METHODS THEREOF
#235CURCUMIN COMPLEX, PREPARATION METHOD THEREFOR AND DETECTION METHOD THEREFOR
#236Aqueous Suspensions of TMC278
#237NANOSPHERES OF SEC14-LIKE PROTEINS AND COGNATE LIGANDS
#238DOSAGE FORM COMPOSITIONS COMPRISING AN INHIBITOR OF BRUTON'S TYROSINE KINASE
#239PROCESS FOR THE PREPARATION OF ABROCITINIB
#240THERAPEUTIC CONSTRUCTS FOR CO-DELIVERY OF MITOTIC KINASE INHIBITOR AND IMMUNE CHECKPOINT INHIBITOR
#241PHARMACEUTICAL FORMULATIONS FOR A LIQUID DOSAGE FORM AND A CONTROLLED RELEASE DOSAGE FORM
#242Pharmaceutical composition and administrations thereof
#243GLYCOPYRROLATE SALTS
#244SOLID DISPERSION AND PREPARATION METHOD THEREFOR
#245DEVICE AND METHOD FOR IMPROVING RETENTION OF A THERAPY IN THE BLADDER
#246Methods of treating ocular diseases using polyalkylene glycol intracameral implants with polyactide travoprost particles
#247Reduction of flake-like aggregation in nanoparticulate active agent compositions
#248COMPOSITIONS COMPRISING CURCUMIN AND COENZYME Q10
#249USE OF GINKGO TERPENE LACTONE IN PREPARING DRUG FOR PREVENTING AND/OR TREATING GUILLAIN-BARRE-STROHL SYNDROME
#250FORMULATIONS OF A COMPOUND MODULATING KINASES
#251ANTIVIRAL PRODRUGS AND NANOFORMULATIONS THEREOF
#252METHODS OF IMPROVING PHARMACEUTICAL SUBSTANCE SOLUBILIZATION AND PRODUCTS THEREOF
#253MULTIFUNCTIONAL POLYMER-NANOPARTICLE COMPOSITE FOR FIRST AID AND WOUND CARE APPLICATIONS
#254NANOPARTICLES OF INDIRUBIN, DERIVATIVES THEREOF AND METHODS OF MAKING AND USING SAME
#255Pharmaceutical compositions
#256Extended nitric oxide-releasing polymers via functionalized mesoporous silica nanoparticles
#257Rapidly infusing platform and compositions for therapeutic treatment in humans
#258Polymer particles
#259EFFLUX INHIBITOR COMPOSITIONS AND METHODS OF TREATMENT USING THE SAME
#260SOLID DISPERSIONS CONTAINING AN APOPTOSIS-INDUCING AGENT
#261PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION OF A BCL 2 FAMILY INHIBITOR
#262STABLE SOLID DISPERSION OF A B-RAF KINASE DIMER INHIBITOR, METHODS OF PREPARATION, AND USES THEREFOR
#263ORAL FORMULATIONS OF A BIOLOGICALLY ACTIVE PEPTIDE AND USES THEREOF
#264Pharmaceutical composition
#265STABLE DRY POWDER COMPOSITION COMPRISING BIOLOGICALLY ACTIVE MICROORGANISMS AND/OR BIOACTIVE MATERIALS AND METHODS OF MAKING
#266COMPOSITIONS AND METHODS FOR INCREASING THE BIOAVAILABILITY OF ONE OR MORE COMPOUNDS
#267Compositions comprising an urolithin compound
#268Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune checkpoint inhibitor
#269PROCESS FOR FRACTIONATING AN ESTERIFIED CELLULOSE ETHER
#270Methods of making and using polyphenols complexed with a protein, peptide, amino acid, polysaccharide, disaccharide, or monosaccharide
#271KIDNEY-TARGETING DRUG DELIVERY CARRIER
#272Light upconversion silica particles
#273Process for preparing pharmaceutical compositions
#274Preparation of solid cyclodextrin complexes for ophthalmic active pharmaceutical ingredient delivery
#275ALCOHOL ANTIDOTE
#276Novel formulation of metaxalone
#277Controlled release dosage form
#278Method for improving the dissolution profile of a biologically active material
#279THERAPEUTIC COMPOUNDS AND USES THEREOF
#280Oral rapamycin nanoparticle preparations and use
#281Snuff composition
#282Pharmaceutical composition and use
#283Discoidal nano universal platform for efficient delivery of PNAs
#284OIL-IN-WATER METHOD FOR MAKING POLYMERIC IMPLANTS CONTAINING A HYPOTENSIVE LIPID
#285Crystalline forms of therapeutic compounds and uses thereof
#286NANOPARTICLES BASED ON OPTIONALLY ALKOXYLATED POLY(ALKYL CYANOACRYLATES) HAVING A DEFINED DEGREE OF POLYMERIZATION
#287BENDAMUSTINE SOLID DISPERSIONS AND CONTINUOUS INFUSION
#288NANOPARTICLE DELIVERY TO A TARGET TISSUE
#289PROCESS FOR MANUFACTURING PHENYLEPHRINE RESINATE PARTICLES; PHENYLEPHRINE RESINATE PARTICLES; AND USE OF PHENYLEPHRINE RESINATE PARTICLES IN PHARMACEUTICAL FORMULATIONS
#290Curcuminoid composites
#291AGENTS FOR ORAL COMPOSITION
#292PROCESSES FOR MAKING CYCLIC LIPID IMPLANTS FOR INTRAOCULAR USE
#293Formation of particles including agents
#294Anticancer compositions
#295Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases
#296AMINE CATIONIC LIPIDS AND USES THEREOF
#297A CELLULAR SOLID MATERIAL DRUG CARRIER COMPRISING CELLULOSE NANOFIBERS (CNF) WHEREIN THE CELLULAR SOLID MATERIAL COMPRISES CLOSED CELLS
#298Controlled release dosage form with enhanced pharmacokinetics
#299High density peptide polymers
#300Amorphous dispersion of 4-methyl-3-quinolin-3-ylethynyl-benzoic acid nā²-(2-chloro-6-methyl-benzoyl) hydrazide